Dipeptidyl peptidase-4 inhibitor treatment could decrease chronic rhinosinusitis in diabetic patients.

MLA

Li, S. Y., et al. “Dipeptidyl Peptidase-4 Inhibitor Treatment Could Decrease Chronic Rhinosinusitis in Diabetic Patients.” QJM: An International Journal of Medicine, vol. 113, no. 3, Mar. 2020, pp. 181–85. EBSCOhost, https://doi.org/10.1093/qjmed/hcz250.

APA

Li, S.-Y., Chen, H.-H., Lai, C.-C., Lin, C.-L., & Kao, C.-H. (2020). Dipeptidyl peptidase-4 inhibitor treatment could decrease chronic rhinosinusitis in diabetic patients. QJM: An International Journal of Medicine, 113(3), 181–185. https://doi.org/10.1093/qjmed/hcz250

Chicago

Li, S -Y, H -H Chen, C -C Lai, C -L Lin, and C -H Kao. 2020. “Dipeptidyl Peptidase-4 Inhibitor Treatment Could Decrease Chronic Rhinosinusitis in Diabetic Patients.” QJM: An International Journal of Medicine 113 (3): 181–85. doi:10.1093/qjmed/hcz250.